Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association

Table 2 Optical coherence tomography findings

	Case 1	case 2	Case 3	Case 4
ODD	No	No	Yes	No
BMO, µm
OD	1355*	1350	1492*	1329*
OS	1445	1383*	1507	1295
GCL Volume, mm³	4 weeks:	3 weeks:	10 weeks:	3 weeks:
OD	0.92*	1.11	0.76*	0.98*
OS	1.05	0.85*	1.31	1.08
IRF/SRF presence*
Peripapillary	Yes	Yes	Yes	Yes
Within ETDRS grid	Yes, within grid II	Yes, within grid II	Yes	Yes

The time in weeks indicates the duration between the patient-reported onset of visual symptoms and the GCL measurements
*Refers to the eye with nonarteritic anterior ischemic optic neuropathy. ODD optic disc drusen, BMO Bruch’s membrane opening, GCL Ganglion cell layer, IRF/SRF intraretinal fluid / subretinal fluid, ETDRS Early treatment diabetic retinopathy study

ISSN: 1471-2415